Functional Mitral and Tricuspid Regurgitation Pathophysiology Assessment and Treatment 1st Editon 2016 Hardbound at Meripustak

Functional Mitral and Tricuspid Regurgitation Pathophysiology Assessment and Treatment 1st Editon 2016 Hardbound

Books from same Author: Kok Meng John Chan

Books from same Publisher: Springer

Related Category: Author List / Publisher List


  • Retail Price: ₹ 13529/- [ 5.00% off ]

    Seller Price: ₹ 12853

Sold By: Book Upload      Click for Bulk Order

Offer 1: Get ₹ 111 extra discount on minimum ₹ 500 [Use Code: Bharat]

Offer 2: Get 5.00 % + Flat ₹ 100 discount on shopping of ₹ 1500 [Use Code: IND100]

Offer 3: Get 5.00 % + Flat ₹ 300 discount on shopping of ₹ 5000 [Use Code: MPSTK300]

Free Shipping (for orders above ₹ 499) *T&C apply.

In Stock

Free Shipping Available



Click for International Orders
  • Provide Fastest Delivery

  • 100% Original Guaranteed
  • General Information  
    Author(s)Kok Meng John Chan
    PublisherSpringer
    Edition1st Edition
    ISBN9783319435084
    Pages222
    BindingHardbound
    LanguageEnglish
    Publish YearNovember 2016

    Description

    Springer Functional Mitral and Tricuspid Regurgitation Pathophysiology Assessment and Treatment 1st Editon 2016 Hardbound by Kok Meng John Chan

    This book covers in detail all aspects of functional mitral and tricuspid regurgitation, from its pathophysiology and natural history, to its assessment, medical and surgical treatment, and long term results. Functional Mitral and Tricuspid Regurgitation encompasses information and knowledge from a diverse background including cardiology, cardiac surgery and basic science. This is necessary for a full understanding of the subject in order to optimally manage patients with this condition. The normal mitral valve and mitral regurgitation.- Pathophysiology of ischemic mitral regurgitation.- Assessment of ischemic mitral regurgitation.- Treatment of ischemic mitral regurgitation.- B-type natriuretic peptide in ischemic mitral regurgitation.- Randomized trials in ischemic mitral regurgitation.- Predictors of outcome.- What still needs to be done.